Lallemand completed the acquisition of Evolva for CHF30m.

Lallemand, a privately owned company, founded at the end of the 19th century that researches, develops, produces and markets yeasts, bacteria and related products, completed the acquisition of Evolva, a biotech researching, developing and commercializing nature-based ingredients, for CHF30m.